Kathy Chu

Kathy Chu is a seasoned professional in global forecasting and commercial analytics, currently serving as Director of Global Forecasting at Mirum Pharmaceuticals, Inc. since March 2024. Previously, Kathy held the position of Associate Director at Gilead Sciences from January 2019 to September 2023, where responsibilities included global forecasting and commercial analytics. At Portola Pharmaceuticals, Kathy contributed as Associate Director, leading global demand forecasting for commercial products and playing a key role in the approval and launch of BevyxXa and AndexXa. Prior experiences include senior managerial roles at Medivation, AcelRx Pharmaceuticals, and project management positions at AlphaDetail and Synovate, showcasing a strong foundation in strategic analytics, business operations, and market research. Kathy holds an MBA from Purdue University, obtained between 2005 and 2007.